XZXuhong Zhang

Xuhong Zhang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Xuhong Zhang has a total of 64 co-authors. Here are the top co-authors by number of shared publications:

  • Shaohua Hu

    Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

    6 shared publications
  • Ye Shen

    Department of Ophthalmology, the First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China

    6 shared publications
  • Jianping Tong

    Department of Ophthalmology, the First Affiliated Hospital of Zhejiang University, Hangzhou, Zhejiang Province, China

    5 shared publications
  • Saboor Saeed

    Department of Psychiatry, the First Affiliated Hospital, Zhejiang University School of Medicine

    5 shared publications
  • Zhixin Lim

    School of Medicine, Zhejiang University, 310003 Hangzhou, Zhejiang, China; Nanhu Brain Computer Interface Institute, 310003 Hangzhou, Zhejiang, China

    4 shared publications
  • Hong Zhu

    Department of Ophthalmology, The First Affiliated Hospital of Zhejiang University, 310003 Hangzhou, Zhejiang, China; Cixi Mingguang Eye Hospital, 315300 Ningbo, Zhejiang, China; School of Medicine, Zhejiang University, 310003 Hangzhou, Zhejiang, China

    3 shared publications

Latest Publications

  • Open Access

    Bridging Three Decades: Global Self-Harm Trends From 1990–2021 and Projections to 2040

    by Hong Zhu, Xuhong Zhang, Tiantian Chen, Zhixin Lim, Saboor Saeed, Jianping Tong, Ye Shen

    Background: Self-harm, which includes both nonsuicidal self-injury and suicidal behaviors, poses a major global public health challenge. This study provides a comprehensive analysis of trends in self-harm worldwide, the socioeconomic disparities associated with it, and future projections, using data from the Global Burden of Disease, Injuries, and Risk Factors Study (GBD) 2021. Methods: Self-harm data were extracted from GBD 2021, including incidence, prevalence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life years(DALYs) for 204 countries and territories from 1990 to 2021. Age-standardized rates and estimated annual percentage change (EAPC) were calculated. Inequality was assessed using the Slope Index of Inequality (SII) and Concentration Index (CI). Autoregressive Integrated Moving Average (ARIMA) models were employed to generate projections of self-harm burden from 2022 to 2040. Results: The global burden of self-harm is projected to change substantially by 2040, with deaths estimated to increase to 829,853 (95% Uncertainty Interval (UI), 262,233–1,397,474) and prevalence projected to rise to 35,863,341 (95% UI, 8,079,108–63,647,574) cases (representing a 131.9% increase from the 2021 baseline of 15,467,153 cases). From 1990 to 2021, age-standardized rates of self-harm demonstrated decreasing trends globally and across sociodemographic index (SDI) levels, with the largest declines observed in high-middle SDI countries. Gender disparities were evident, with more pronounced decreases in females. Inequalities in DALYs due to self-harm decreased over time but remained higher among females in lower-SDI populations. Conclusions: Despite decreasing age-standardized rates, the global burden of self-harm is projected to increase substantially by 2040, with driven by increasing incidence and prevalence in incidence and prevalence. Inequities persist, particularly among females in lower-SDI populations. Implementation of targeted prevention and intervention strategies, strengthening of mental health systems, and addressing social determinants of health are imperative to reduce the growing burden of self-harm worldwide.

  • Open Access

    Circadian rhythms in major depressive disorder: mechanistic insights and therapeutic frontiers

    by Saboor Saeed, Ruiqi Sang, Lim Zhixin, Huaizhi Wang, Le Xu, Xuhong Zhang, Shaohua Hu

    Major Depressive Disorder (MDD) has emerged as a leading cause of disability worldwide, affecting over 264 million people. Recent evidence reveals that disruption of circadian rhythms may be fundamental to MDD pathophysiology, opening new avenues for therapeutic intervention. This review synthesizes current understanding of the intricate relationship between circadian system disruption and MDD, highlighting molecular mechanisms and clinical implications. We examine evidence from genetic studies, clinical observations, and therapeutic trials. Patients with MDD exhibit profound alterations in circadian-regulated processes, including sleep-wake cycles, diurnal mood patterns, and metabolic functions. Genetic studies have identified variants in core clock genes, particularly CLOCK, TIMELESS, and CRY1, that correlate with both circadian disruption and MDD susceptibility. These genetic insights, combined with evidence of dysregulated hypothalamus-pituitary-adrenal axis function and abnormal melatonin signaling, suggest that circadian dysfunction may be causal in MDD pathogenesis rather than merely symptomatic. Emerging chronotherapeutic approaches, such as light therapy, sleep interventions, and targeted pharmacology, show significant potential for improving depressive symptoms. Personalized circadian-based treatments, guided by genetic and molecular markers, could transform MDD care. Advancing our understanding of the circadian-depression connection offers a promising path to revolutionizing treatment strategies.


  • Correction to: Life Cycle and Circadian Rhythms in Central Resident Immunity and Neuropsychiatric Pathology

    by Zhixin Lim, Ha Linh Nguyen, Yuanyuan Zeng, Qingyue Qu, Yan Le, Ming Sun, Xiaoyu Wang, Hong Zhu, Yuchen Qian, Saboor Saeed, et al.

  • Eye–brain axis: Ocular and visual pathophysiology as driver and therapeutic target across the mood disorder trajectory

    by Xuhong Zhang, Xiaoyu Wang, Hong Zhu, Huiwen Yu, Lin Fu, Wanyi Shu, Xihang Ye, Zhixin Lim, Saboor Saeed, Ha Linh Nguyen, et al.

  • Life Cycle and Circadian Rhythms in Central Resident Immunity and Neuropsychiatric Pathology

    by Zhixin Lim, Ha Linh Nguyen, Yuanyuan Zeng, Qigngyue Qu, Yan Le, Ming Sun, Xiaoyu Wang, Hong Zhu, Yuchen Qian, Saboor Saeed, et al.

    The central resident immune system, commonly known as the glial system, comprises various glial cells that play a critical role in neuropsychiatric disorders. However, a systematic review exploring the relationships between the life cycles and daily rhythms of these immune cells and the pathological features of neuropsychiatric disorders is lacking. These immune cells exhibit unique developmental origins and circadian characteristics, resulting in rhythmic variations in functions such as phagocytosis, immune clearance, neurogenesis, and neurotransmitter recycling. These properties are crucial for understanding the pathological mechanisms underlying developmental disorders like major depressive disorder, autism spectrum disorder, and schizophrenia, as well as age-related conditions such as Alzheimer’s and Parkinson’s diseases. The daily rhythms of these immune cells correlate with diurnal variations in emotion, cognition, and motor function, involving shared processes like oxidative stress and neuroinflammation. This article systematically reviews the composition, life cycle changes, and circadian characteristics of central immune cells, highlighting their roles in neuropsychiatric diseases.


  • Mapping the Global Burden and Inequalities of Bipolar Disorder, 1990–2021, With Projections to 2050: A Systematic Analysis

    by Saboor Saeed, Zeyu Luo, Huaizhi Wang, Le Xu, Xuhong Zhang, Anying Tang, Xinxu Ma, Jianbo Lai, Peige Song, Shaohua Hu

    Background: Bipolar disorder is a severe mental disorder affecting millions worldwide, necessitating comprehensive policies and interventions. Aims: To provide assessment of global inequalities in the burden of bipolar disorder and their projected trajectories to 2050. Methods: Global Burden of Disease 2021 data from 204 countries and territories were analyzed, stratified by age, gender, and Socio‐demographic Index (SDI) quintiles. Age‐standardized prevalence (ASPR), incidence (ASIR), and years lived with disability (ASR YLD) per 100,000 population were calculated. Inequalities were assessed using the slope index of inequality (SII) and concentration index (CI), and ARIMA models were applied to project trends to 2050. Results: From 1990 to 2021, global incidence of BD increased, while prevalence and years lived with disability (YLDs) remained relatively stable (ASPR: 453.7 [95% UI: 381.6–540.8] to 454.6 [95% UI: 377.9–545.8]). Females consistently had higher prevalence than males (474.2 vs. 435.0 per 100,000 in 2021). High‐SDI regions reported the highest rates, with Australasia reaching 1110.8 (95% UI: 940.3–1305.9). The SII for incidence rose slightly (10.87–11.38), while the CI declined (0.096–0.012), indicating increasing absolute but decreasing relative inequalities. Projections suggest a rising global burden, with female prevalence remaining higher and incidence rates converging between genders (global ASIR: 33.8 per 100,000). Conclusion: Global inequalities in bipolar disorder persist, disproportionately affecting females and high‐SDI regions. Projected trends indicate an increasing burden with a narrowing gender gap in incidence, emphasizing the need for targeted interventions and further research on long‐term impacts, including the effects of COVID‐19.


  • Open Access

    Spatiotemporal Immune Dynamics in Experimental Retinal Ganglion Cell Injury Models

    by Chongqing Yang, Xiaoyu Wang, Xihang Ye, Ye Shen, Jianping Tong, Xuhong Zhang, Yudong Zhou

    Background: The damage and regeneration of retinal ganglion cells (RGCs) have been extensively studied. Among them, immune cells in different parts of the visual pathway play an important role in injury, regeneration and repair, but a comprehensive analysis of their spatial and temporal distribution is lacking. Purpose: This review emphasizes the unique characteristics of immune cells within the visual input pathway, focusing on their spatiotemporal dynamics in the retina, optic nerve head (ONH), and optic nerve during glaucoma and traumatic optic nerve injury. Methods: A comprehensive search was conducted across PubMed and Web of Science up to April 2025. Studies were included if they reported immune cells under glaucoma or optic nerve crush (ONC) animal models. Findings: Each region of the visual input pathway displays a distinct immune cell composition, including Müller cells, microglia, astrocytes, T cells, and oligodendrocytes, all of which work together to maintain homeostasis and respond to injury. Some immune cells are specific to certain regions, while others are shared across areas. Furthermore, even within a single glial cell type, there are different subtypes with unique developmental origins or marker profiles, reflecting a range of functions. In both glaucoma and traumatic optic nerve injury, retinal immune cells are rapidly activated, regardless of whether the initial impairment occurs in the soma or axon of RGCs, in the subacute or chronic course. The early stages of injury also see the presence of adaptive immune cells, such as T cells and neutrophils. Macrophages and microglia typically play complementary roles, while astrocytes show prolonged activation compared to microglia in the optic nerve, though this pattern does not hold in the retina following ONC. Conclusions: Understanding the spatiotemporal dynamics of these immune responses in glaucoma and traumatic optic nerve injury is crucial for developing targeted therapies that can reduce RGC loss, mitigate neurotoxicity, and promote functional recovery, ultimately preventing vision impairment. Targeting specific immune cell subsets may provide new strategies for delaying RGC damage.


  • Machine learning-enhanced mapping of suicide risk in Bipolar Disorder: A multi-modal analysis

    by Saboor Saeed, Huaizhi Wang, Lingzhuo Kong, Yimeng Geng, Jinyu Zhang, Yanmeng Pan, Xu Le, Xuhong Zhang, Ting Ting Liu, Shaohua Hu


  • Open Access

    Characterization of Retinal VIP-Amacrine Cell Development During the Critical Period

    by Xuhong Zhang, Xiaoyu Wang, Yanqing Li, Yingying Zhang, Hong Zhu, Chen Xie, Yudong Zhou, Ye Shen, Jianping Tong

    Retinal vasoactive intestinal peptide amacrine cells (VIP-ACs) play an important role in various retinal light-mediated pathological processes related to different developmental ocular diseases and even mental disorders. It is important to characterize the developmental changes in VIP-ACs to further elucidate their mechanisms of circuit function. We bred VIP-Cre mice with Ai14 and Ai32 to specifically label retinal VIP-ACs. The VIP-AC soma and spine density generally increased, from postnatal day (P)0 to P35, reaching adult levels at P14 and P28, respectively. The VIP-AC soma density curve was different with the VIP-AC spine density curve. The total retinal VIP content reached a high level plateau at P14 but was decreased in adults. From P14 to P16, the resting membrane potential (RMP) became more negative, and the input resistance decreased. Cell membrane capacitance (MC) showed three peaks at P7, P12 and P16. The RMP and MC reached a stable level similar to the adult level at P18, whereas input resistance reached a stable level at P21. The percentage of sustained voltage-dependent potassium currents peaked at P16 and remained stable thereafter. The spontaneous excitatory postsynaptic current and spontaneous inhibitory postsynaptic current frequencies and amplitudes, as well as charge transfer, peaked at P12 to P16; however, there were also secondary peaks at different time points. In conclusion, we found that the second, third and fourth weeks after birth were important periods of VIP-AC development. Many developmental changes occurred around eye opening. The development of soma, dendrite and electrophysiological properties showed uneven dynamics of progression. Cell differentiation may contribute to soma development whereas the changes of different ion channels may play important role for spine development. Graphical Abstract The second, third and fourth weeks after birth were important periods of VIP-AC development. VIP::Ai14 and VIP::Ai32 mice were used for soma and spine analysis, respectively. The developmental curves for VIP-AC soma have a distinct and longer platform, whereas the developmental curves for spine have a longer and smoother slopes. When the number of VIP-AC some is increasing, cell differentiation may play an important role. During the development of spine, the development of different ion channels is the most vital events. Kv-Ka represents the ion channels that conduct Ka, Kv-Kdr represents the ion channels that conduct Kdr, GABAR represents the inhibitory transmission and NMDAR represents the excitatory transmission. The events occur chronologically from left to right.


  • Top Cited Papers
    Open Access

    The role of the PI3K/AKT signalling pathway in the corneal epithelium: recent updates

    by Kuangqi Chen, Yanqing Li, Xuhong Zhang, Rahim Ullah, Jianping Tong, Ye Shen

    Phosphatidylinositol 3 kinase (PI3K)/AKT (also called protein kinase B, PKB) signalling regulates various cellular processes, such as apoptosis, cell proliferation, the cell cycle, protein synthesis, glucose metabolism, and telomere activity. Corneal epithelial cells (CECs) are the outermost cells of the cornea; they maintain good optical performance and act as a physical and immune barrier. Various growth factors, including epidermal growth factor receptor (EGFR) ligands, insulin-like growth factor 1 (IGF1), neurokinin 1 (NK-1), and insulin activate the PI3K/AKT signalling pathway by binding their receptors and promote antiapoptotic, anti-inflammatory, proliferative, and migratory functions and wound healing in the corneal epithelium (CE). Reactive oxygen species (ROS) regulate apoptosis and inflammation in CECs in a concentration-dependent manner. Extreme environments induce excess ROS accumulation, inhibit PI3K/AKT, and cause apoptosis and inflammation in CECs. However, at low or moderate levels, ROS activate PI3K/AKT signalling, inhibiting apoptosis and stimulating proliferation of healthy CECs. Diabetes-associated hyperglycaemia directly inhibit PI3K/AKT signalling by increasing ROS and endoplasmic reticulum (ER) stress levels or suppressing the expression of growth factors receptors and cause diabetic keratopathy (DK) in CECs. Similarly, hyperosmolarity and ROS accumulation suppress PI3K/AKT signalling in dry eye disease (DED). However, significant overactivation of the PI3K/AKT signalling pathway, which mediates inflammation in CECs, is observed in both infectious and noninfectious keratitis. Overall, upon activation by growth factors and NK-1, PI3K/AKT signalling promotes the proliferation, migration, and anti-apoptosis of CECs, and these processes can be regulated by ROS in a concentration-dependent manner. Moreover, PI3K/AKT signalling pathway is inhibited in CECs from individuals with DK and DED, but is overactivated by keratitis.